EL.En. (ELN) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
31 Oct, 2026Executive summary
FY23 revenue rose 2.8% to €692.290m; EBITDA fell 4.6%, EBIT 10.2% and net income 12.5% YoY.
Record Q4 revenue reached €199.278m, up 5.3% YoY; second-half cash generation improved year-end net financial position to €54.586m from €75.363m.
Financial highlights
FY23 gross margin rose 4.7% to €261.430m; gross margin increased to 37.8% from 37.1%.
EBITDA was €90.866m, down 4.6%; EBIT was €72.736m, down 10.2%; net income was €48.239m, down 12.5%.
Q4 revenue rose 5.3% to €199.278m; EBITDA increased 4.7% to €28.985m while EBIT declined 9.2% to €20.958m YoY.
Operating expenses rose 5.7% and staff expenses rose 13.2%; parent-company revenue declined 11.3% to €137.7m.
Outlook and guidance
FY24 revenue and EBIT are expected to exceed FY23 levels; sales and order intake started slowly in the first two months, with acceleration expected thereafter.
Delivery against guidance depends partly on industrial operations in China, where performance has been unstable and unpredictable.
Technology innovations are planned for launch in 2024; medium- to long-term market prospects remain positive.
Latest events from EL.En.
- Medical sector growth and divestment drove 9.1% revenue and 45.5% net profit increase in H1 2026.ELN
Q2 2026 - Medical sector growth drove Q1 revenue and margin gains, offsetting industrial weakness.ELN
Q1 2026 - 2025 revenues set to reach €590.8M, driven by innovation and global expansion.ELN
Investor presentation - Revenue up 4.4% to €591M, net profit down 15.9%, strong cash, positive 2026 outlook.ELN
Q4 2025 - Revenue up 5.1% to €285.3M; EBIT and net income down; Chinese unit divested.ELN
Q2 2025 - Net income rose 5.9% to €27.3M as EBIT fell 12.1% but margins and cash flow remained strong.ELN
H1 2024 - 59% stake in Chinese laser unit sold to YOFC; financial position and 2025 outlook improve.ELN
Investor Update - Net income up 7% to €51.6M as medical growth offset industrial decline; 2025 outlook cautious.ELN
Q4 2024 - Q1 2025 revenue up 8.8%, EBIT up 12%, strong growth in all segments, 2025 outlook confirmed.ELN
Q1 2025